SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-001859
Filing Date
2017-03-31
Accepted
2017-03-31 09:34:45
Documents
11
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_033017.htm 20-F 2359069
2 EXHIBIT 12.1 exh_121.htm EX-12.1 9937
3 EXHIBIT 12.2 exh_122.htm EX-12.2 9997
4 EXHIBIT 13.1 exh_131.htm EX-13.1 3781
5 EXHIBIT 13.2 exh_132.htm EX-13.2 3636
6 GRAPHIC chart_01.jpg GRAPHIC 14751
7 GRAPHIC chart_02.jpg GRAPHIC 22988
8 GRAPHIC chart_03.jpg GRAPHIC 13520
9 GRAPHIC chart_04.jpg GRAPHIC 15746
10 GRAPHIC chart_05.jpg GRAPHIC 27065
11 GRAPHIC pwc.jpg GRAPHIC 2235
  Complete submission text file 0001171843-17-001859.txt   2520956
Mailing Address UNIT 4/476 GARDENERS ROAD ALEXANDRIA, NSW C3 2015
Business Address UNIT 4/476 GARDENERS ROAD ALEXANDRIA, NSW C3 2015 61 2 9667 4411
Parnell Pharmaceuticals Holdings Ltd (Filer) CIK: 0001603429 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 001-36494 | Film No.: 17728281
SIC: 2834 Pharmaceutical Preparations